Drug facts
MoleculeFerumoxytol (Feraheme)
Generics already compete: 1 maker on the market. 1 A-rated product from 1 maker substitute at the counter.
Feraheme was first approved by the FDA on 06/30/2009 under NDA 022180; the application holder is Azurity Pharmaceuticals Inc.
Holder Azurity Pharmaceuticals IncApplication NDA 022180Approved 06/30/2009
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Feraheme patent listed in the Orange Book Orange Book
02Competition
- Generics
- 1 generic maker Orange Book
- First generic approved
- 01/15/2021 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Ferumoxytol profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
04Product
- Application holder
- Azurity Pharmaceuticals Inc Orange Book
- Application
- NDA 022180 Orange Book
- First approved
- 06/30/2009 Orange Book
- Dosage forms
- solution
- Routes
- intravenous
- Other brand names
- Ferabright
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.